post-bariatric hypoglycemia Eiger BioPharmaceuticals

Eiger BioPharmaceuticals completes enrolment in Prevent trial

Eiger BioPharmaceuticals has completed patient enrolment in the Phase ll Prevent trial evaluating the safety and durability of subcutaneous (SC)…